MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E

Macro Group Pharmaceuticals (Macro Capital) S.A.E

MCRO

EGS7D971C011

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 18:00:00 2024-05-15 EDT			5-day change	1st Jan Change
2.13 ^EGP	+3.40%		-1.84%	-27.80%

04-16	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Rimco EGT Investment acquired 3.2% stake in Macro Group Pharmaceutical for EGP 61.5 million.

March 28, 2023

Rimco EGT Investment acquired 3.2% stake in Macro Group Pharmaceutical for EGP 61.5 million on March 29, 2023.
Rimco EGT Investment completed the acquisition of 3.2% stake in Macro Group Pharmaceutical on March 29, 2023.

Latest news about Macro Group Pharmaceuticals (Macro Capital) S.A.E

Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023	04-16	CI
Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-15	CI
Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-16	CI
Rimco EGT Investment acquired 3.2% stake in Macro Group Pharmaceutical for EGP 61.5 million.	23-03-28	CI
Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-02	CI
Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-04	CI
Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-29	CI
Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-07	CI

Chart Macro Group Pharmaceuticals (Macro Capital) S.A.E

Duration

Period

Chart Macro Group Pharmaceuticals (Macro Capital) S.A.E

More charts

Company Profile

Macro Group Pharmaceutical S.A.E. (Macro Capital) is specialized in developing, manufacturing and marketing pharmaceuticals. The company's products include anti-scar, skincare, antiseptic, hair care, oral care and muscle relaxant medicines. In addition, the group offers plant-based medicines. At the end of 2021, Macro Group Pharmaceutical S.A.E. (Macro Capital) had one production site in Egypt.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.13 EGP

Average target price

5.3 EGP

Spread / Average Target

+148.83%

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E	-27.80%	25.57M
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B

Other Pharmaceuticals

Macro Group Pharmaceuticals (Macro Capital) S.A.E

Equities

MCRO

EGS7D971C011

Pharmaceuticals

Rimco EGT Investment acquired 3.2% stake in Macro Group Pharmaceutical for EGP 61.5 million.

Latest news about Macro Group Pharmaceuticals (Macro Capital) S.A.E

Chart Macro Group Pharmaceuticals (Macro Capital) S.A.E

Company Profile

Income Statement Evolution

Analysts' Consensus

Annual profits - Rate of surprise

Sector Other Pharmaceuticals